China Pharma (CPHI) Competitors $1.89 +0.04 (+2.16%) As of 12:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock CPHI vs. NNVC, ALVR, PMN, SONN, PASG, TAOX, SNYR, QTTB, NAII, and CTXRShould you be buying China Pharma stock or one of its competitors? The main competitors of China Pharma include NanoViricides (NNVC), AlloVir (ALVR), Promis Neurosciences (PMN), Sonnet BioTherapeutics (SONN), Passage Bio (PASG), Synaptogenix (TAOX), Synergy CHC (SNYR), Q32 Bio (QTTB), Natural Alternatives International (NAII), and Citius Pharmaceuticals (CTXR). These companies are all part of the "pharmaceutical products" industry. China Pharma vs. Its Competitors NanoViricides AlloVir Promis Neurosciences Sonnet BioTherapeutics Passage Bio Synaptogenix Synergy CHC Q32 Bio Natural Alternatives International Citius Pharmaceuticals China Pharma (NYSE:CPHI) and NanoViricides (NYSE:NNVC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk. Do institutionals and insiders hold more shares of CPHI or NNVC? 10.3% of NanoViricides shares are held by institutional investors. 17.3% of China Pharma shares are held by company insiders. Comparatively, 4.6% of NanoViricides shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has better earnings & valuation, CPHI or NNVC? China Pharma has higher revenue and earnings than NanoViricides. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina Pharma$4.40M1.40-$3.08MN/AN/ANanoViricidesN/AN/A-$8.29M-$0.70-2.06 Does the media prefer CPHI or NNVC? In the previous week, NanoViricides had 1 more articles in the media than China Pharma. MarketBeat recorded 2 mentions for NanoViricides and 1 mentions for China Pharma. China Pharma's average media sentiment score of 0.00 beat NanoViricides' score of -0.05 indicating that China Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment China Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NanoViricides 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, CPHI or NNVC? China Pharma has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, NanoViricides has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Is CPHI or NNVC more profitable? NanoViricides has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. China Pharma's return on equity of -63.93% beat NanoViricides' return on equity.Company Net Margins Return on Equity Return on Assets China Pharma-85.56% -63.93% -31.42% NanoViricides N/A -87.90%-78.69% SummaryChina Pharma beats NanoViricides on 6 of the 10 factors compared between the two stocks. Get China Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CPHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CPHI vs. The Competition Export to ExcelMetricChina PharmaPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$6.17M$835.24M$5.72B$21.38BDividend YieldN/A4.84%5.72%3.50%P/E RatioN/A1.1875.1029.76Price / Sales1.4026.60498.5667.82Price / CashN/A19.5625.8118.13Price / Book2.706.6513.234.60Net Income-$3.08M-$4.13M$3.28B$998.80M7 Day Performance4.42%2.17%0.32%0.89%1 Month Performance32.17%7.61%4.73%4.28%1 Year Performance-90.55%23.37%73.16%14.04% China Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CPHIChina Pharma0.31 of 5 stars$1.89+2.2%N/A-91.9%$6.17M$4.40M0.00250News CoverageNNVCNanoViricides0.2202 of 5 stars$1.46+1.4%N/A-9.9%$23.47MN/A-2.0320Gap UpALVRAlloVirN/A$4.64+0.4%N/A-77.5%$23.40MN/A-0.23110Gap DownHigh Trading VolumePMNPromis Neurosciences3.6751 of 5 stars$0.42-3.7%$4.33+929.3%-66.0%$22.64MN/A-2.005Positive NewsShort Interest ↓Gap UpSONNSonnet BioTherapeutics2.8756 of 5 stars$3.12-5.2%$20.00+541.0%-14.6%$22.46M$20K0.0010Positive NewsGap UpHigh Trading VolumePASGPassage Bio4.1019 of 5 stars$7.00+1.2%$75.67+981.0%-56.9%$22.00MN/A-0.39130News CoverageInsider TradeTAOXSynaptogenix0.0708 of 5 stars$6.24-0.5%N/AN/A$21.86MN/A-0.314SNYRSynergy CHC3.9666 of 5 stars$2.24-2.2%$10.00+346.4%N/A$21.62M$34.83M5.8940QTTBQ32 Bio2.7683 of 5 stars$1.78+1.7%$12.17+583.5%-96.1%$21.35M$1.16M-0.4139NAIINatural Alternatives International1.6515 of 5 stars$3.34-2.2%N/A-48.0%$21.07M$113.80M-2.40290Short Interest ↓CTXRCitius Pharmaceuticals2.5245 of 5 stars$1.21-0.8%$53.00+4,280.2%-91.2%$20.75MN/A0.0020Analyst UpgradeShort Interest ↑ Related Companies and Tools Related Companies NanoViricides Competitors AlloVir Competitors Promis Neurosciences Competitors Sonnet BioTherapeutics Competitors Passage Bio Competitors Synaptogenix Competitors Synergy CHC Competitors Q32 Bio Competitors Natural Alternatives International Competitors Citius Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CPHI) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CPHI Stock Alerts